WUXI BIOLOGICS DL-,000025 Forum: Community User: Summer.76

Ist halt ein China-Wert und die Risikoabwägung solltest du entsprechend für dich treffen. Als "neue Luckin Coffee" sehe ich sie jedoch nicht.

Für wie riskant erachtet ihr hier ein Investment?

Xiaomi’s spectacular gain outshines Alibaba and Wuxi Biologics in first week since trio tapped for Hang Seng Index https://www.scmp.com/business/companies/article/3098494/xiaomis-spectacular-gain-outshines-alibaba-and-wuxi-biologics Investors trying to capitalise quickly on the announced reshuffling of the Hang Seng Index were richly rewarded if they piled into Chinese smartphone maker Xiaomi this past week. It jumped 18.4 per cent, much more than e-commerce giant Alibaba and pharmaceutical developer Wuxi Biologics, the other two stocks that will be added to the board on September 7. ... Meanwhile, Wuxi Biologics’s share price shot up 10.5 per cent, while the weekly gain of Alibaba, which owns the South China Morning Post, was just 2.4 per cent. “They are likely to go up … I think they would still go up towards that [inclusion] day,” Alex Wong, director of asset management at Ample Capital, said of the prospects of Xiaomi, Wuxi Biologics and Alibaba in the run-up to September 7. “[We] see a round of buying before the addition,” said Wong. “And then, after the addition, it really depends on fundamentals. … I think Alibaba may be the best one to own, and would have some upside later on. I think Wuxi and Alibaba actually would still outperform after addition.”

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1036675/latest-news

http://www.aastocks.com/en/stocks/news/aafn-con/NOW.1036648/company-news M Stanley Adds WUXI BIO (02269.HK) TP to $210; Rated Overweight

Falls der link hängen sollte, dann sollte dieser klappen: https://www.bloomberg.com/news/videos/2020-08-18/wuxi-biologics-covid-19-antibody-products-out-by-year-end-video?theme=2&_v=1&color=1&hl=en&sp=1

Wuxi Biologics: Covid-19-Antikörperprodukte zum Jahresende erhältlich https://finance.yahoo.com/video/wuxi-biologics-covid-19-antibody-071125241.html Chris Chen, Chief Executive Officer bei Wuxi Biologics Cayman Inc., erläutert die Ergebnisse des ersten Halbjahres, die Fortschritte bei den Covid-19-Behandlungen und die Expansionspläne des Unternehmens. 

WuXi Biologics posts strong H1 growth despite pandemic disruptions https://seekingalpha.com/news/3606375-wuxi-biologics-posts-strong-h1-growth-despite-pandemic-disruptions Shrugging off COVID-19-related disruptions, WuXi Biologics (OTCPK:WXXWY) delivered a 21.0% increase in H1 revenue (RMB1,944.1M). Gross profit surged 17.3% to RMB787.3M. Profit was up 62.6% to RMB730.7M. EPS rose 55.9% to RMB0.53. Non-GAAP EPS was up 38.5% to RMB0.54. Total backlog jumped more than 85% to US$9,464.0M primarily due to a 20-year vaccine manufacturing and supply contract and addition of COVID-19 projects. As part of its expansion in the U.S., it bought land in Worcester, MA, for a new commercial manufacturing facility, leased a 33K sq. ft. site in King of Prussia, PA, for a process development lab and inked a 10-year lease for a clinical manufacturing facility in Cranbury, NJ.

WuXi Biologics Records Excellent Interim Results https://www.prnewswire.com/news-releases/wuxi-biologics-records-excellent-interim-results-301113279.html

Wer hier auch baldmöglichst einsteigen.

Alibaba und Xiaomi: Milliarden‑Beben im Top‑Index https://www.deraktionaer.de/artikel/aktien/alibaba-und-xiaomi-milliarden-beben-im-top-index-20205567.html Neben den AKTIONÄR-Empfehlungen Alibaba und Xiaomi zieht auch Wuxi Biologics in den Hang Seng ein. Die Unternehmen ersetzen am 7. September Sino Land, Want Want China und China Shenhua Energy. Alibaba, Xiaomi und Meituan Dianping werden zudem in den H-Share-Index aufgenommen, in dem sich ausschließlich chinesische Unternehmen befinden. Im Hang Seng sind die 50 größten Unternehmen der Hongkonger Börse vertreten. Den Index gibt es seit 1969. Bislang waren Aktien mit einer Erstnotierung an einer anderen Börse oder verschiedenen Gattungen (Beispiel: Stück- und Namensaktie) von einer Aufnahme in den Index ausgeschlossen ... Die Veränderungen im Index zwingen Fonds, die den Hang Seng physisch nachbilden wollen, zum Kauf der neuen Mitglieder. In Produkten, die an den Hang Seng und den H-Share-Index gekoppelt sind, stecken mehrere Milliarden Dollar. Unternehmen, die Mitglied in einem großen Index sind, ziehen zudem in der Regel zusätzliche Aufmerksamkeit auf sich, und es fließt mehr institutionelles Kapital in die entsprechenden Aktien. Für die Kurse von Alibaba und Xiaomi ist die Nachricht aus Hongkong also rundum positiv.

https://www.scmp.com/business/banking-finance/article/3097458/alibaba-xiaomi-wuxi-biologics-win-green-light-join-hang Alibaba, Xiaomi, WuXi Biologics win green light to join the Hang Seng Index on September 7 ... WuXi Biologics, China's largest drugs development and manufacturing services provider, will also be added to the 50 constituent stocks in the index. The decision, announced by index compiler Hang Seng Indexes Company on Friday in its quarterly review, is the biggest revamp of the 50-year-old Hang Seng Index since the inclusion of mainland companies listed in Hong Kong, known as H-shares, in 2006. ...

https://www.fiercepharma.com/manufacturing/wuxi-biologics-taps-veteran-insider-to-head-fledging-vaccine-cdmo-business

https://www.prnewswire.com/news-releases/wuxi-vaccines-appoints-mr-jian-dong-as-chief-executive-officer-301107379.html

👍😎

Danke fürs Teilen, Summer.76😊👍🏼